| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.3 | 3.3 | 28.7 | 42.3 | 34.8 | 51.0 | +46.6% | |
| Cost of revenue | 2.5 | 2.5 | 16.7 | 28.7 | 30.3 | 33.8 | +11.5% | |
| Gross profit | 3.8 | 0.8 | 12.0 | 13.6 | 4.4 | 17.2 | +287.1% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Selling, general & administrative | 0.1 | 0.1 | 1.2 | 3.0 | 2.4 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 0.1 | 0.2 | 1.6 | 3.6 | 3.1 | 3.1 | +1.0% | |
| Operating income | 3.7 | 0.6 | 10.4 | 10.1 | 1.4 | 14.1 | +930.8% | |
| Interest expense | 0.0 | 0.0 | 1.4 | 2.5 | 0.4 | 0.2 | −33.3% | |
| Interest income | 0.0 | 0.0 | 0.0 | 1.0 | 0.3 | 0.7 | +100.8% | |
| Other income / expense | (0.0) | (0.0) | (1.1) | (12.8) | 9.1 | — | — | |
| Pre-tax income | 3.6 | 0.6 | 9.3 | (2.7) | 10.5 | 21.1 | +101.2% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | 3.6 | 0.6 | 9.3 | (2.7) | 10.5 | 21.0 | +100.7% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | 246,092.00 | 36,772.00 | 204,838.00 | (3,603.60) | 325.48 | 14,994.44 | +4506.9% | |
| EPS, diluted (per share) | 246,092.00 | 36,772.00 | 204,838.00 | (3,603.60) | 27.84 | 4,020.49 | +14341.4% | |
| EBITDA | 4.1 | 1.1 | 14.8 | 5.9 | 17.3 | 19.0 | +9.4% | |
| Depreciation & amortization | 0.4 | 0.6 | 4.1 | 6.2 | 6.5 | 7.0 | +7.3% | |
| Weighted average shares (shares) | 15 | 15 | 42 | 2,245 | 12,852 | — | — | |
| Weighted average diluted shares (shares) | 15 | 15 | 42 | 2,245 | 50,007 | — | — | |
| Gross margin | 60.3% | 22.8% | 41.8% | 32.2% | 12.8% | 33.7% | +20.9 pts | |
| Operating margin | 58.3% | 16.8% | 36.3% | 23.8% | 3.9% | 27.6% | +23.7 pts | |
| Net margin | 57.5% | 16.8% | 32.3% | −6.5% | 30.1% | 41.2% | +11.1 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
